Smartleaf Asset Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$460K Hold
2,125
0.02% 572
2026
Q1
$399K Buy
2,125
+273
+15% +$50.3K 0.01% 586
2025
Q4
$327K Buy
1,852
+1,224
+195% +$200K 0.01% 627
2025
Q3
$87K Buy
628
+426
+211% +$57.6K 0.01% 1142
2025
Q2
$25.5K Sell
202
-125
-38% -$15.6K ﹤0.01% 1453
2025
Q1
$45.3K Sell
327
-144
-31% -$20.6K ﹤0.01% 1199
2024
Q4
$70.8K Buy
471
+52
+12% +$8.77K 0.01% 1011
2024
Q3
$81.7K Buy
419
+272
+185% +$56.9K 0.01% 771
2024
Q2
$33.6K Buy
147
+60
+69% +$13K 0.01% 844
2024
Q1
$18.8K Buy
87
+67
+335% +$15.7K ﹤0.01% 867
2023
Q4
$5.21K Buy
+20
New +$4.91K ﹤0.01% 862

Other funds holding BIIB

Smartleaf Asset Management's BIIB Position: Q2 2026 in Review

Smartleaf Asset Management held its Biogen (BIIB) position steady in Q2 2026 at 2,125 shares worth $460K. The position accounts for 0.02% of the portfolio, ranked #572.

Smartleaf Asset Management first reported a position in BIIB in Q4 2023 and has held it in 11 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Smartleaf Asset Management held 2,125 shares of Biogen worth $460K as of Q2 2026.
  • Smartleaf Asset Management left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.02% of Smartleaf Asset Management's portfolio in Q2 2026, its #572 holding.
  • Smartleaf Asset Management first reported a position in Biogen in Q4 2023 and has held it in 11 quarters since.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.